Kelly Olson is currently the Oncology Medical Director at AstraZeneca, where they leverage extensive expertise in Medical Affairs, Oncology pathways, and healthcare quality and policy. Having held various roles at AstraZeneca from 2019 to 2023, including Clinical Account Director and Scientific Partnership Medical Director, Kelly has demonstrated proficiency in product launch planning and strategy execution across multiple tumor types. Prior to their tenure at AstraZeneca, they worked as a Consultant Pharmacist at Omnicare and held several positions that enhanced their skills in clinical consulting and medical science liaison roles. Kelly earned a Doctor of Pharmacy (Pharm.D.) from St. Louis College of Pharmacy and completed a Primary Care/Teaching Residency at Midwestern University Chicago College of Pharmacy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices